Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 42/100 | DilutionWatch score record |
| Shares Outstanding | 99.45M | Verified float table or market cache |
| Public Float | 42.45M | Verified float table or market cache |
| Market Cap | $381.38M | Market data cache |
| Cash Runway | 16.5 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 2.
Recent SEC source mix: XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
SPRY SEC Filing Activity — Last 12 Months
Shares outstanding reported by SPRY on the cover page of its latest 10-K/10-Q: 99.45M as of August 11, 2026.
DilutionWatch recorded no shelf, registration or prospectus documents for SPRY in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 8-K | current report (material event) | 4 | Jul 07, 2026 |
| 10-K | annual report | 1 | Mar 09, 2026 |
| 10-Q | quarterly report | 1 | May 15, 2026 |
| DEF 14A | proxy statement | 1 | Apr 29, 2026 |
| 3 | initial insider ownership | 4 | Jul 14, 2026 |
| 5 | annual insider ownership | 16 | Oct 01, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual SPRY Dilution Snapshot
ARS Pharmaceuticals, Inc. (SPRY) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: October 27, 2026.
- Recent SEC activity tracked for SPRY: xbrl on 2024-03-21; xbrl on 2024-03-21.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
SPRY's DilutionScore is currently 42/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 38/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Aug 22 – Oct 27, 2026 | 42/100 | MEDIUM | 67 days |
| Jul 30 – Aug 21, 2026 | 38/100 | MEDIUM | 22 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
SPRY shares outstanding have increased 0.5% from 98.85M (Mar 2026) to 99.30M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 25, 2026 | 99.30M | 42.45M | ▲ 8.36% |
| May 18, 2026 | 99.30M | 39.17M | ▼ 4.55% |
| Apr 07, 2026 | 99.30M | 41.04M | ▼ 1.26% |
| Mar 27, 2026 | 99.30M | 41.56M | ▼ 11.48% |
| Mar 12, 2026 | 98.85M | 46.95M | ▲ 0.51% |
| Mar 11, 2026 | 98.85M | 46.71M | ▼ 49.77% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.